Canine Cancer Research

Concurrent use of chemotherapy and Immunocidin® for treatment of canine Lymphoma and OsteosarcomaJeannette Kelly, Megan Padget, Miriam Cervantes (oral presentation at the 2019 Veterinary Cancer Society Annual Conference - Houston, TX, USA - October, 2019)

Clinical and safety evaluation of multiple intravenous administrations of Immunocidin® in cats and dogs with malignanciesJeannette Kelly, Megan Padget, Chad Johannes, Alexandar Masic (oral presentation at the 2018 ACVIM Forum - Seattle, WA, USA - June, 2018)

Mycobacterium Cell Wall Fraction (MCWF) as an aid in the treatment of chemotherapy-induced neutropenia in dogsJuan Mangieri, Lucas Rodrigues, Aleksandar Masic (oral presentation at the 2016 ACVIM Forum - Denver, Colorado, USA - June, 2016)

Serum cytokine induction after a single Mycobacterium Cell Wall Fraction (MCWF) treatment in tumor-bearing dogsMartins, M.; Losowski, L.; Masic, A.; Prunic, B.; Rodrigues, LCS (oral presentation at the 3rd World Veterinary Cancer Congress 2016 - Foz do Iguassu, Brazil - May, 2016)

Mycobacterium Cell Wall-DNA complex (MCW-DNA) as an aid in the treatment of chemotherapy-induced neutropenia in healthy dogsAleksandar Masic, Bojana Prunic, Lucas Rodrigues (oral presentation at the 3rd World Veterinary Cancer Congress 2016 - Foz do Iguassu, Brazil - May, 2016)

Efficacy of Mycobacterium Cell Wall-DNA complex (MCW-DNA) in the prevention of chemotherapy-induced neutropenia following concurrent administration. Aleksandar Masic, Bojana Prunic, Lucas Rodrigues (poster presented at the 3rd World Veterinary Cancer Congress 2016 - Foz do Iguassu, Brazil - May, 2016)

Mycobacterium Cell Wall Fraction (IMMUNOCIDIN®) for canine transitional cell carcinoma treatment. Lucas Rodrigues, Aleksandar Masic, Stan Alkemade, Vladimir Kukolj, Mirtes Martins, Elis Montini (oral presentation at the Veterinary Cancer Society Annual Conference 2015 - Vienna, Virginia, U.S.A. - October, 2015)

Safety profile of Mycobacterium Cell Wall Fraction (IMMUNOCIDIN®) following multiple intravenous administrations in healthy dogs. Juan Mangieri, Rodrigo de Haro, Lucas Rodrigues, Vladimir Kukolj, Bojana Prunic, Aleksandar Masic (poster presented at the Veterinary Cancer Society Annual Conference 2015 - Vienna, Virginia, U.S.A. - October, 2015)